| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S2468-1253(17)30365-5 |
| P698 | PubMed publication ID | 29254618 |
| P2093 | author name string | Vlad Ratziu | |
| P2860 | cites work | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Q29617157 |
| Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease | Q34574104 | ||
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Q34676840 | ||
| Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study | Q36292220 | ||
| Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop | Q36987260 | ||
| A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver | Q38105838 | ||
| Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. | Q39283211 | ||
| Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study | Q39671232 | ||
| Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort | Q40701165 | ||
| Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team | Q42274136 | ||
| Population-based risk factors and resource utilization for HCC: US perspective | Q42953743 | ||
| NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study | Q46084938 | ||
| Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study | Q46774699 | ||
| Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease | Q49647333 | ||
| When the journey from obesity to cirrhosis takes an early start. | Q54411104 | ||
| P433 | issue | 1 | |
| P921 | main subject | end-stage liver disease | Q54974362 |
| P304 | page(s) | 8-10 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | The lancet. Gastroenterology & hepatology | Q27727626 |
| P1476 | title | The painful reality of end-stage liver disease in NASH. | |
| P478 | volume | 3 |
Search more.